Skip to content
Screener

Common Stock at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
AbbVie logo
AbbVieABBV
$18M0.0%
IAR
Integra LifeSciencesIART
240M0.0%
Artivion logo
ArtivionAORT
75M0.0%
Globus Medical logo
Globus MedicalGMED
775M0.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$4.07M+3.2%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemJune 30,2026December 31,2025
Total liabilities330,319333,620
Commitments and contingencies (Note 7)
Shareholders’ equity:
Common shares — zero par value, unlimited amount authorized; 30,201,123 and 29,713,024 shares issued at June 30, 2026 and December 31, 2025, respectively; 29,793,053 and 29,304,954 shares outstanding at June 30, 2026 and December 31, 2025, respectively450,587433,378
Additional paid-in-capital92,60387,624
Treasury shares, at cost, 408,070 shares held at June 30, 2026 and December 31, 2025(2,854)(2,854)
Accumulated deficit(520,886)(495,756)
Accumulated other comprehensive income2,1571,155

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's common stock?
Establishment Labs (ESTA) reported common stock of $450.59M in Q2 2026.
How has Establishment Labs's common stock changed year-over-year?
Establishment Labs's common stock increased by 5.8% year-over-year, from $425.86M to $450.59M.
What is the long-term trend for Establishment Labs's common stock?
Over 5 years (2020 to 2025), Establishment Labs's common stock has grown at a 15.2% compound annual growth rate (CAGR), from $213.47M to $433.38M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Establishment Labs's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude